Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility.

Introduction: Available data on women fertility for younger patients treated using RIC Allo-SCT are still limited. We evaluated ovarian function and fertility among female patients younger than 35 years who received RIC Allo-SCT for hematological malignancy or aplastic anemia (AA).

Patients And Methods: Information on therapies before RIC Allo-SCT were collected.